⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
Alzheimer's Drug Discovery Foundation Launches Milestones in Motion Campaign and Announces Fifth Season of Symposium Series in Palm Beach
prnewswire.com
BIIB
CDNA
New data on lecanemab to be presented at CTAD conference
prnewswire.com
BGXX
ESAIY
BIIB
Biogen and Stoke Therapeutics Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments
globenewswire.com
BIIB
STOK
Stoke Therapeutics and Biogen Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments
businesswire.com
STOK
BIIB
High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy
globenewswire.com
BIIB
IONS
Biogen Completes Acquisition of Alcyone Therapeutics
globenewswire.com
BIIB
IONS
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
globenewswire.com
BIIB
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
globenewswire.com
BIIB
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
globenewswire.com
BIIB
Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors
prnewswire.com
BIIB
IFF